AcquisitionOther
Vertex Pharmaceuticals Incorporated acquired Crinetics Pharmaceuticals, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Vertex Pharmaceuticals Incorporated -> Crinetics Pharmaceuticals, Inc. · $10.0 billion
To add commercialized PALSONIFY (acromegaly) and Phase 3 atumelnant (CAH/Cushing's) to expand endocrinology portfolio.
Open source record (SEC) ↗